Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Parkwalk Advisors

WebsiteLinkedInTwittercbCrunchbase
Status
ACTIVE
Global HQ
London, United Kingdom
Countries of investment
  • United Kingdom
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • MedTech
  • Biotechnology
  • Deep Tech
About
Parkwalk Advisors specializes in identifying and backing university spinouts from the UK, particularly those commercializing advanced scientific research. Their approach centers on providing capital to early-stage, deep-tech companies that are founded on solid intellectual property developed within prestigious academic institutions. Parkwalk works closely with founders to help them transition from academic research into scalable commercial ventures, supporting them through critical early-stage development to ensure their technologies can reach the market effectively and efficiently.
Min check size
$25K
Max check size
$20M
Fund size
NPS

Investment Thesis

Parkwalk Advisors strategically focuses on investing in university spinouts that leverage breakthrough academic research to build scalable, defensible deep-tech businesses. The firm’s thesis centers on the long-term potential of science-based innovation emerging from the UK’s top universities. By investing at early stages through EIS funds, Parkwalk seeks to bridge the gap between academia and commercialization—transforming world-class intellectual property into market-leading enterprises. The firm believes that early exposure to IP-rich sectors like life sciences, quantum technologies, and advanced engineering provides both societal and economic returns.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Founded by experienced investment professionals with decades in venture and private equity, focused on early-stage technology and healthcare companies.

Parkwalk Advisors Contacts Information

Primary contact

Secondary contact

Team

Alastair Kilgour – Co-Founder & Chief Investment Officer

Alun Williams – Investment Director

Amy Virdee – Legal Counsel

Anne Dobrée – Investment Director

Chloe Woodacre – Head of Investor Relations

Georgia Docker – Senior Investor Relations Associate

Gordon Lawson – Non-Executive Chairman

Harriet Doherty – Business Development & Head of Marketing

Ian Broadhurst – Investor Director

John Pearson – Chief Investment Officer

Kathy Samii – Chief Operating Officer

Martin Glen – Investment Director

Moray Wright – Chief Executive Officer

Neil Cameron – Investment Director

Steve Churchhouse – Entrepreneur-in-Residence

Susie Harris – Director of Business Development.

Portfolio

Cambridge GaN Devices

Crypto Quantique

Barocal

Xampla

Paragraf

Sorex Sensors

Congenica

AccelerComm

Brainomix

Zomp

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp